Dynavax Technologies Corp DVAX
$15.50
Last Updated: Feb 09, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
DVAX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Dynavax Technologies Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Dynavax Technologies Corp. Stock Analysis DVAX
United States Health Care Small Cap Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. The company is headquartered in Emeryville, California and currently employs 405 full-time employees. The company went IPO on 2004-02-19. The firm has two commercial products: HEPLISAV-B vaccine (Hepatitis B Vaccine (Recombinant), Adjuvanted), and CpG 1018 adjuvant. The HEPLISAV-B vaccine is used for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose in-one-month adult hepatitis B vaccine. CpG 1018 adjuvant is used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. The firm is advancing a pipeline of differentiated product candidates that leverage its CpG 1018 adjuvant to develop improved vaccines in indications with unmet medical needs. Its pipeline programs include Shingles vaccine program (Z-1018) and Plague vaccine program. Z-1018 is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.
Dynavax Technologies Corp (DVAX) Chart
Financial Metrics & Statements of Dynavax Technologies Corp (DVAX)
FAQ's for Dynavax Technologies Corp (DVAX)
- As of August 2026, Dynavax Technologies Corp DVAX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Dynavax Technologies Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Dynavax Technologies Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Dynavax Technologies Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Dynavax Technologies Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Dynavax Technologies Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Dynavax Technologies Corp (DVAX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
